Skip to main content

Day: January 27, 2021

SCHWEITZER-MAUDUIT INTERNATIONAL, INC. ANNOUNCES OFFER TO ACQUIRE UK-BASED SCAPA GROUP PLC, BEST-IN-CLASS INNOVATION, DESIGN, & MANUFACTURING SOLUTIONS PROVIDER FOR HEALTHCARE & INDUSTRIAL MARKETS

Alpharetta, Jan. 27, 2021 (GLOBE NEWSWIRE) —SIGNIFICANT EXPANSION OF SWM’S CORE COMPETENCIES’, COMBINED WITH NEW CAPABILITIES, TO BRING CUSTOMERS A MORE COMPREHENSIVE SUITE OF SOLUTIONSWITH THE ACQUISITION, ANNUALIZED ADVANCED MATERIALS SEGMENT SALES APPROACHING $1 BILLION, ENHANCING SWM’S LONG-TERM GROWTHINVESTOR CALL SCHEDULED FOR JANUARY, 27 AT 11:00 AM ETSchweitzer-Mauduit International, Inc. (“SWM” or the “Company“) (NYSE: SWM) today announced that it has reached an agreement with the Board of Scapa Group, Plc (“Scapa”) (LSE: SCPA) on the terms of a recommended cash offer (to be made by SWM’s wholly owned indirect subsidiary) for the acquisition of the entire share capital of Scapa, a UK-based innovation, design, and manufacturing solutions provider for healthcare and industrial markets. Pursuant to...

Continue reading

Interim report for Q1 2020/21

Ambu delivered organic revenue growth of 39% in Q1. The demand for single-use endoscopes is positively influenced by COVID-19. Commercial launch of aScope™ Duodeno is on track, and clinical trial has commenced. Ambu intends to raise approx. DKK 1.3bn of capital to ensure strategic and operational flexibility. Full-year outlook is maintained.“We reached revenue of one billion DKK this quarter for the first time in Ambu’s history. This milestone is the result of the dedication and focus of our organization in the midst of the COVID-19 pandemic. We’re leading the creation of the single-use endoscopy market to help hospitals take care of patients without risk of cross-contamination. Our modular R&D engine is helping us deliver technologically advanced products with an attractive economic offering across all endoscopy segments,” said...

Continue reading

Ambu A/S seeks to strengthen its capital base

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL.Ambu A/S seeks to strengthen its capital baseAmbu A/S (“Ambu” or the “Company”) intends to raise approximately DKK 1.3 billion of new capital through an offering of new B shares and existing treasury B shares (together the “Shares”) to be completed through an accelerated bookbuilding offering (the “Offering”) in a private placement directed at institutional and professional investors in Denmark and certain other jurisdictions.AttachmentCompany announcement no. 6 2020_21

Continue reading

BW Energy: No subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF ANERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE “UNITED STATES”), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to the stock exchange notice by BW Energy Limited (“BW Energy” or the “Company”) on 21 January 2021 announcing the successful completion of a private placement or 23,690,000 new shares at a subscription price of NOK 27 per share...

Continue reading

Orocobre Limited Quarterly Report of Operations for the Period Ended 31 December 2020

BRISBANE, Australia, Jan. 27, 2021 (GLOBE NEWSWIRE) —DECEMBER QUARTER 2020 KEY HIGHLIGHTS1Olaroz Lithium Facility (Olaroz) operations returned to being Gross Cash Margin positive with record sales volume during the quarter while costs declined to near all-time lows. Quarterly production volumes were the third highest since operations commenced. Low costs and strong, stable production mean the business is well positioned to participate in the improving lithium market. Operations continued under the established Bio-Security Protocol with limits on the number of personnel on site for both production and expansion works.OLAROZ LITHIUM FACILITY (ORE 66.5%)2Activities continue to focus on the health and well-being of our staff, contractors and communities while maintaining production and expansion worksOlaroz operations stopped for two...

Continue reading

Shoals Technologies Group, Inc. Announces Pricing of Upsized Initial Public Offering

PORTLAND, Tenn., Jan. 26, 2021 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) today announced the pricing of its upsized initial public offering of 77,000,000 shares of its Class A common stock at a price to the public of $25.00 per share. The offering consists of 9,000,000 shares of Class A common stock being sold by the Company and 68,000,000 shares of Class A common stock being sold by a parent entity of the Company controlled by funds managed by Oaktree Capital Management, L.P. (the “Selling Stockholder”). In addition, the Company and the Selling Stockholder granted the underwriters a 30-day option to purchase up to an additional 11,550,000 shares (the “Additional Shares”) at the public offering price, less underwriting discounts and commissions. The Additional Shares consist of up to 2,550,000 shares of...

Continue reading

Constellation Software Inc. Announces Release Date for Fourth Quarter Results

TORONTO, Jan. 26, 2021 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced today it will release its fourth quarter results on February 12, 2021.The Company’s quarterly results will be disseminated via press release and made available on the Company’s website (www.csisoftware.com) and SEDAR, after the Toronto Stock Exchange closes on Friday, February 12, 2021.   As outlined in Constellation’s press release on February 23, 2018, Constellation has ceased holding conference calls to discuss the Company’s quarterly financial results. In lieu of the quarterly calls the Company has created a link on its website where shareholders can submit questions to management. Periodically the Company will publish responses to selected questions received. The Company believes this Q&A facility will eventually prove to be a more...

Continue reading

Dorel to Appeal Decision Rendered by Luxembourg Administrative Tribunal

MONTRÉAL, Jan. 26, 2021 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) (“Dorel”) announces that it intends to appeal a decision of the Luxembourg Administrative Tribunal received on January 22, 2021 with respect to taxation on the transfer of certain assets in connection with an internal corporate reorganization that took place in 2015. The decision of the Luxembourg Administrative Tribunal concluded, in effect, that one of Dorel’s wholly-owned subsidiaries owes €46.8 million (euros) in tax (US $56.9 million) plus applicable interest.Forward-looking statements made in this press release, including statements relating to the appeal referred to above, are based on a number of assumptions that Dorel believed were reasonable on the day it made the forward-looking statements. Factors that could cause actual results to differ...

Continue reading

Dorel compte interjeter appel d’une décision rendue par le Tribunal administratif du Luxembourg

MONTRÉAL, 26 janv. 2021 (GLOBE NEWSWIRE) — Les Industries Dorel Inc. (TSX : DII.B, DII.A) (« Dorel ») annonce qu’elle entend interjeter appel d’une décision rendue par le Tribunal administratif du Luxembourg et reçue le 22 janvier 2021 au sujet de l’imposition du transfert de certains actifs dans le cadre d’une réorganisation corporative interne qui a eu lieu en 2015. Le Tribunal administratif du Luxembourg confirme dans sa décision que l’une des filiales en propriété exclusive de Dorel doit 46,8 M€ (euros) en impôts (soit 56,9 M$ US), plus les intérêts applicables.Les énoncés prospectifs contenus dans le présent communiqué de presse, y compris les énoncés portant sur l’appel susmentionné, sont fondés sur plusieurs hypothèses que Dorel estimait raisonnables le jour où elle a formulé ces énoncés prospectifs. Les facteurs susceptibles...

Continue reading

Predictive Oncology Announces Closing of $4.1 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

MINNEAPOLIS, Jan. 26, 2021 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously announced registered direct offering of 3,414,970 shares of its common stock, at a purchase price of $1.20 per share, which was priced at-the-market under Nasdaq rules. The gross proceeds to the Company from this offering were approximately $4.1 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. In a concurrent private placement, the Company also issued to the same investors unregistered warrants to purchase up to an aggregate of 1,707,485 shares of common stock at an exercise price of $1.37 per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.